Selumetinib Cleared for Adults With Neurofibromatosis Type 1 – Medscape

Written by

admin

in

  1. Selumetinib Cleared for Adults With Neurofibromatosis Type 1  Medscape
  2. FDA Approves Selumetinib for Adults With Neurofibromatosis Type 1  The American Journal of Managed Care® (AJMC®)
  3. AstraZeneca says Koselugo (Selumetinib) approved in the US  MarketScreener
  4. Key facts: AstraZeneca’s Koselugo gains FDA approval; stock rises 1.4%  TradingView
  5. AstraZeneca receives US FDA approval for Koselugo in adults with NF1  Investing.com

Continue Reading

More posts